Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

727.21 -15.70 (-2.11%)
Official Closing Price Updated: 7:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
1 Growth Stock Down 40% to Buy and Hold Forever
Via The Motley Fool
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company. 
Via The Motley Fool
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
EQNX::TICKER_START (NYSE:ATNM),(NYSE:BMY),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
Organovo Provides Business Update
From Organovo, Inc.
Via GlobeNewswire
Price Targets Show These 3 Stocks Near the $1 Trillion Mark
See what analysts' price targets say about the prospects of these three stocks flirting with the $1 trillion valuation mark. 
Via MarketBeat
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed. 
Via Benzinga
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study
The "rapid" enrollment suggests there's still huge interest in the company's approach to obesity treatment. 
Via Investor's Business Daily
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
According to Direxion CEO Douglas Yones, Eli Lilly and Palo Alto Networks are prime candidates for leveraged trading. 
Via Benzinga
Topics ETFs
Direxion Expands Single Stock Leveraged & Inverse ETF Lineup for Exposure to Eli Lilly & Palo Alto Networks
Extends Leadership Role with First-Ever Palo Alto Networks Trading Pair, Alongside New Pharma Trades 
Via News Direct
Topics ETFs
2 No-Brainer Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
From Organovo, Inc.
Via GlobeNewswire
Eli Lilly Shares Rise Over 2% After Key Signal
A significant trading signal occurred for Eli Lilly stock, as it demonstrated a Power Inflow at $849.02, after which LLY rose up to 2.1% 
Via Benzinga
5 Stocks That Could Be The Next Nvidia
 
Via Benzinga
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. 
Via The Motley Fool
Eli Lilly Unusual Options Activity
 
Via Benzinga
Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.
Novo Nordisk is now planning to take on Eli Lilly's experimental retatrutide, a triple agonist for weight loss and diabetes. 
Via Investor's Business Daily
Market Sell-Off: Can Buying These 3 "Safe" Stocks Today Set You Up for Life?
These fundamentally strong stocks remain safer picks, despite the heightened market volatility. 
Via The Motley Fool
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid... 
Via Benzinga
Topics World Trade
Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks
Instead of chasing returns, investors can start building long-term passive income through dividend growth stocks. 
Via Talk Markets
Topics Stocks / Equities
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stock 
Via MarketBeat
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Via The Motley Fool
Eli Lilly Shares Are Up Today: What's Going On?
Eli Lilly & Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in India. 
Via Benzinga
Behind the Scenes of Eli Lilly's Latest Options Trends
 
Via Benzinga
5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Via The Motley Fool
3 Market-Beating Stocks to Target This Week
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the... 
Via StockStory
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug. 
Via MarketBeat
Why Hims & Hers Stock Popped on Monday
Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock? 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly
 
Via Benzinga
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Via The Motley Fool
Top 10 High Alpha Stocks For Dividend Investors
Most investors are seeking outperformance when buying stocks. One of the most popular measures of investment outperformance is alpha. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.